戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n inverse association between involution and mammographic density.
2 er through a mechanism that includes reduced mammographic density.
3 otect against breast cancer is by decreasing mammographic density.
4 cer risk, particularly among women with high mammographic density.
5 isted thresholding method to measure percent mammographic density.
6 carotenoids and breast cancer risk varies by mammographic density.
7  breast cancer risk through its influence on mammographic density.
8  and breast cancer risk among women with low mammographic density.
9 ng carotenoids are inversely associated with mammographic density.
10 last four factors were associated with lower mammographic density.
11 women in the United Kingdom are reflected in mammographic density.
12 a reasonable intervention approach to reduce mammographic density.
13 vely associated (free estradiol) with higher mammographic density.
14 atistically significantly related to greater mammographic density.
15 cer risk and, less consistently, with higher mammographic density.
16  in stiff breast tissue from women with high mammographic density.
17  in the breast epithelium of women with high mammographic density.
18 ere length and MDA in their association with mammographic density.
19 orresponds to the collagen component at high mammographic density.
20 breast cancer risk is not fully explained by mammographic density.
21 he SNP most strongly associated with percent mammographic density.
22  associated with both breast cancer risk and mammographic density.
23 d by highest and lowest quartiles of percent mammographic density.
24 wer risk factors, such as polygenic risk and mammographic density.
25 signaling has been associated with increased mammographic density.
26 ent to reduce cancer risk in women with high mammographic density.
27 .27 to 0.93) compared with women with stable mammographic density.
28  be partially due to negative confounding by mammographic density.
29 st cancer risk remained after adjustment for mammographic density.
30 association between AR-CAG repeat length and mammographic density, a strong breast cancer risk factor
31 as tailored to lifetime risk (Gail test) and mammographic density (according to Breast Imaging Report
32                                      Percent mammographic density adjusted for age and body mass inde
33                                 High-percent mammographic density adjusted for age and body mass inde
34                     We studied the change in mammographic density after a breast cancer diagnosis and
35   Previous studies have linked reductions in mammographic density after a breast cancer diagnosis to
36                                A decrease in mammographic density after breast cancer diagnosis appea
37                 Here, we tried to observe if mammographic density also affects the hormone receptor s
38  treatment is associated with a reduction in mammographic density and an improved survival.
39 oses of tamoxifen were noninferior to reduce mammographic density and associated with fewer symptoms.
40 r evidence of a shared genetic basis between mammographic density and breast cancer and illustrate th
41 authors investigated the association between mammographic density and breast cancer risk among women
42 uate the strength of the association between mammographic density and breast cancer risk using differ
43  To maximize statistical power in studies of mammographic density and breast cancer, it is advantageo
44 ations of plasma leptin and adiponectin with mammographic density and disease status and assessed the
45 onectin levels were directly associated with mammographic density and HDL cholesterol and negatively
46 ons of the breast images to characterize the mammographic density and heterogeneity of dense portions
47                                              Mammographic density and lobular involution are both sig
48 requiring that women be informed about their mammographic density and related adjunct imaging.
49 e genome-wide association studies of percent mammographic density and report an association with rs10
50                      At lower levels of MDA, mammographic density and telomere length were inversely
51 s evidence of a J-shaped association between mammographic density and telomere length.
52 n ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.
53     The associations are independent of BMI, mammographic density, and treatment.
54                                  Tumor size, mammographic density, and US characteristics may be indi
55                        Ethnic differences in mammographic density are consistent with those for breas
56 e results provide new insights into how high mammographic density arises and why it is associated wit
57 within-cohort percentile changes) with adult mammographic density, assessed using a computer-assisted
58 reast cancer are based on questionnaires and mammographic density assessments.
59 le predictors of breast cancer risk, but few mammographic density-associated genetic variants have be
60 ingdom population-based multiethnic study of mammographic density at ages 50-64 years in 645 women.
61 n a subset of patients with IC who had a low mammographic density at prior screening examination.
62                                  The percent mammographic density at the first available mammogram wa
63 ated with a weaker annual decline in percent mammographic density by 0.09% (standard error = 0.03; P
64                                  We measured mammographic density by a computer assisted method and b
65                                     However, mammographic density cannot be used as a clinical indica
66 tatistically significant association between mammographic density change and survival.
67                                              Mammographic density change is a proxy for tamoxifen the
68 ine symptoms, tamoxifen discontinuation, and mammographic density change.
69  normal breast epithelium of women with high mammographic density, correlated positively with epithel
70 ted with placebo, 1, 2.5, 5, and 10 mg whose mammographic density decreased at least as much as the m
71                                  Conversely, mammographic density does not appear to explain the inve
72 dy of the magnitude and meaning of increased mammographic density due to use of estrogen and estrogen
73       However, the extent to which change in mammographic density during adjuvant tamoxifen therapy c
74 ssion adjusted for age, available prior MRI, mammographic density, examination year, and multiple ris
75    Interval breast cancers in women with low mammographic density have the most aggressive phenotype.
76 larly, among women in the highest tertile of mammographic density, high levels of circulating alpha-c
77 countries in the International Consortium on Mammographic Density (ICMD).
78                                   Background Mammographic density improves the accuracy of breast can
79                         Age-adjusted percent mammographic densities in Afro-Caribbeans and South Asia
80 hysical activity, body mass index (BMI), and mammographic density in a racially/ethnically diverse po
81       We examined the effect of CEE alone on mammographic density in a subsample of the Women's Healt
82  conjugated equine estrogens (CEEs) alone on mammographic density in diverse racial/ethnic population
83 st prominent difference between low and high mammographic density in healthy breast tissue by PARADIG
84  masking, and risk-surpasses measurements of mammographic density in identifying patients for supplem
85 y measured circulating carotenoid levels and mammographic density in the Nurses' Health Study.
86                                         High mammographic density is a strong breast cancer risk fact
87                                              Mammographic density is a strong risk factor for breast
88                                    Extensive mammographic density is a strong risk factor for breast
89                                              Mammographic density is a well-established risk factor f
90                                              Mammographic density is an independent risk factor for b
91             In longitudinal studies, greater mammographic density is associated with an increased ris
92                                    Increased mammographic density is associated with increased breast
93                                              Mammographic density is associated with increased breast
94                               In this study, mammographic density is measured by using a fully automa
95                                              Mammographic density is one of the strongest predictors
96                                              Mammographic density is positively associated with plasm
97            In this study we examined whether mammographic density is related to blood telomere length
98 investigated whether the level of decline in mammographic density is related to breast cancer risk us
99                                              Mammographic density is strongly associated with breast
100 matrix (ECM) stiffness, associated with high mammographic density, is linked to increased breast canc
101 and estrogen-progestins is warranted because mammographic density may be a marker for risk for breast
102 studies suggest that the association between mammographic density (MD) and breast cancer risk might b
103  has been set at either low or high level of mammographic density (MD) and the organoid models are ex
104                                              Mammographic density (MD) is one of the strongest breast
105 g carotenoids and genetic predispositions or mammographic density (MD) may help inform more effective
106                                              Mammographic density (MD) phenotypes are strongly associ
107  and epidemiological factors associated with mammographic density (MD) phenotypes.
108 ted 10-year breast cancer risk score (TCRS), mammographic density (MD), and a 77-single nucleotide po
109 colony organization, at the maximum level of mammographic density (MD), are investigated.
110                                    Increased mammographic density (MD), the proportion of dense tissu
111 ty on breast cancer risk may be mediated via mammographic density (MD).
112 icroenvironment is increased to that of high mammographic density (MD).
113 n may be an important genetic determinant of mammographic density measure that predicts breast cancer
114 y variants were associated with at least one mammographic density measure.
115 ssociations between reproductive factors and mammographic density measured using processed FFDM image
116 s demonstrate the robustness of quantitative mammographic density measurements across FFDM and film m
117                                              Mammographic density measurements are associated with ri
118                                   Background Mammographic density measurements are used to identify p
119                                              Mammographic density measures adjusted for age and body
120                    They had a total of 6,317 mammographic density measures available from the first 5
121 ociated with both breast cancer risk and the mammographic density measures.
122 gram was evaluated and compared with that of mammographic density models.
123 aracteristics (n = 4,091), risk factors, and mammographic density (n = 1,957) were included.
124                      Almost all increases in mammographic density occurred within the first year.
125 = 0.36) became positive after adjustment for mammographic density (odds ratio = 1.28, 95% confidence
126                                   Conclusion Mammographic density on FFDM images was positively assoc
127 omere length was not associated with percent mammographic density or dense area, before or after adju
128 positive outcome (P > .05), although greater mammographic density (P = .022) and younger age (< 50 ye
129  (Beta coefficients express the increment in mammographic density per-unit increment (pg/ml) of each
130 ome-wide association studies (GWAS) of three mammographic density phenotypes: dense area, non-dense a
131                                      Percent mammographic density (PMD) adjusted for age and body mas
132 rses' Health Study II, whose data on percent mammographic density (PMD) and absolute area of dense ti
133 somatotype at age 18, benign breast disease, mammographic density, polygenic risk score, family histo
134 dentify etiologic pathways implicated in how mammographic density predicts breast cancer risk.
135             The participants had noninferior mammographic density reduction following 2.5, 5, and 10
136 ired response to tamoxifen, measured through mammographic density reduction.
137                                              Mammographic density reflects the amount of stromal and
138 study suggests that absolute but not percent mammographic density reflects the lower breast cancer in
139               The authors determined whether mammographic density reflects these ethnic differences b
140 e clinical significance of the CEE effect on mammographic density remains to be determined.
141                      Women with high and low mammographic density showed similar aAUCs.
142                                     However, mammographic density significantly modified the associat
143 etween siblings in the Early Determinants of Mammographic Density study (1959-2008; n = 700 women wit
144 spective data from the Early Determinants of Mammographic Density Study (n = 1,108; 1959-2008), we ex
145 spective data from the Early Determinants of Mammographic Density study (United States, 1959-2008, n
146 lation of the epithelium in a mouse model of mammographic density supported a causal relationship bet
147 st but statistically significant increase in mammographic density that is sustained over at least a 2
148 ciations between endogenous sex steroids and mammographic density, the authors conducted a 1998-2005
149                                      Percent mammographic density, the proportion of dense breast tis
150 udy, we show that epithelial cells from high mammographic density tissues have more DNA damage signal
151 onse compared with epithelial cells from low mammographic density tissues.
152 s seen in desmoplastic and disease-free high mammographic density tissues.
153  risk for developing cancer, especially high mammographic density tissues.
154 rted lifestyle and familial risk factors and mammographic density to estimate risk.
155 ome-wide association study (GWAS) of percent mammographic density to identify novel genetic loci asso
156        Among women in the highest tertile of mammographic density, total carotenoids were associated
157  use, and body mass index predict changes in mammographic density trends during adult life.
158 ample of 479 individuals from the Australian Mammographic Density Twins and Sisters was used for disc
159               Interreader agreements for the mammographic density types and CT density grades were de
160 igher for the CT density grades than for the mammographic density types, with 0.79 (95% confidence in
161 tative descriptors for the physical finding, mammographic density, US characteristics in the area of
162 0, a single reader reassessed all images for mammographic density using Cumulus software (Sunnybrook
163 .6 years, the mean annual decline in percent mammographic density was 1.1% (standard deviation = 0.1)
164                                    Change in mammographic density was calculated as percentage change
165                                              Mammographic density was classified according to Breast
166                                              Mammographic density was estimated as the four-category
167                                    Change in mammographic density was measured and used as a proxy fo
168                                              Mammographic density was measured by using a computer-as
169                                              Mammographic density was measured by using an automated
170            The ethnic difference in absolute mammographic density was particularly evident among wome
171                    Mean age-adjusted percent mammographic density was significantly higher in Asian A
172 uctive factors, and family history, absolute mammographic density was statistically significantly low
173                         Absolute and percent mammographic densities were determined with a previously
174     At 12 months, the odds of an increase in mammographic density were 13.1 (95% CI, 2.4 to 73.3) wit
175 s central), amount of FGT at MR imaging, and mammographic density were assessed on index images.
176   We examined whether age-related changes in mammographic density were different for 533 cases and 1,
177 ed breast cancer after adjusting for age and mammographic density were family history of breast cance
178   BPE pattern, MR imaging amount of FGT, and mammographic density were not significantly different be
179 val breast cancers in dense breasts (> 40.9% mammographic density) were less aggressive than interval
180  breast cancers in nondense breasts (</= 20% mammographic density) were significantly more likely to
181  changes have been associated with decreased mammographic density, which itself is strongly associate
182 hat stiff breast tissue from women with high mammographic density, who exhibit increased lifetime ris
183 tive would have a greater decline in percent mammographic density with age, compared with less physic
184 se results and to examine the association of mammographic density with age-related chronic disease an
185                          The associations of mammographic density with breast cancer and the model fi

 
Page Top